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i 
Abstract 
Lakio S., 2010. Towards real-time understanding of processes in pharmaceutical 
powder technology. 
 
Dissertationes bioscientiarum molecularium Universitatis Helsingiensis in Viikki, 8/2010, pp. 68. 
 
ISBN 978-952-10-6167-7 (paperback), ISBN 978-952-10-6168-4 (PDF), ISSN 1795-7079 
 
 
There is a need for better understanding of the processes and new ideas to develop 
traditional pharmaceutical powder manufacturing procedures. Process analytical 
technology (PAT) has been developed to improve understanding of the processes and 
establish methods to monitor and control processes. The interest is in maintaining and 
even improving the whole manufacturing process and the final products at real-time. 
Process understanding can be a foundation for innovation and continuous improvement in 
pharmaceutical development and manufacturing. New methods are craved for to increase 
the quality and safety of the final products faster and more efficiently than ever before. 
The real-time process monitoring demands tools, which enable fast and noninvasive 
measurements with sufficient accuracy. Traditional quality control methods have been 
laborious and time consuming and they are performed off line i.e. the analysis has been 
removed from process area. Vibrational spectroscopic methods are responding this 
challenge and their utilisation have increased a lot during the past few years. In addition, 
other methods such as colour analysis can be utilised in noninvasive real-time process 
monitoring. 
 
In this study three pharmaceutical processes were investigated: drying, mixing and 
tabletting. In addition tablet properties were evaluated. Real-time monitoring was 
performed with NIR and Raman spectroscopies, colour analysis, particle size analysis 
and compression data during tabletting was evaluated using mathematical modelling. 
These methods were suitable for real-time monitoring of pharmaceutical unit operations 
and increase the knowledge of the critical parameters in the processes and the phenomena 
occurring during operations. They can improve our process understanding and therefore, 
finally, enhance the quality of final products. 
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1. Introduction 
The field of pharmaceutical powder technology is under continuous changes and 
researchers have to be able to respond this challenge. The goal for pharmaceutical 
industry is to increase the quality of products, decrease the production costs and reduce 
the time of new products to come on market.  
 
Formulations that are manufactured from powders and granules, such as tablets and 
capsules, are the most used dosage forms (Lieberman et al., 1993; Muzzio et al., 2002; 
Wells and Aulton, 2007). Therefore the knowledge of the physical properties of solid 
materials is crucial. However, pharmaceutical powder technology is still mainly 
considered more as an art than a science (Lanz, 2006). Thus behaviour of powders and 
granules during pharmaceutical processing is only partly known and profound 
understanding is needed from behaviour of powders and granules (Muzzio et al., 2002). 
For instance the tabletting process is invented already over 150 years ago, and tablets are 
the most used dosage form in the world (Alderborn, 2007). Nevertheless, it is still a 
challenging task to assure the reproducible quality of tablets from batch to batch.  
 
As pharmaceutical products become more complex, regulatory requirements for product 
will also become demanding, requiring much better understanding and control of product 
properties and process attributes. There is a need for better understanding of the processes 
and new ideas to develop traditional manufacturing procedures. Recent developments in 
the pharmaceutical technology are related to process analytical technology (PAT). PAT 
has been developed to improve our understanding of the pharmaceutical process and to 
monitor and to control critical process parameters (US Food and Drug Administration, 
2004). The interest is in maintaining and even improving the whole manufacturing 
process and the final products at real-time. The real-time process monitoring demands 
tools, which enable fast and noninvasive measurements with sufficient accuracy. 
Traditional quality control methods have been laborious and time-consuming and they 
are performed off line i.e. the analysis has been removed from process area. Vibrational 
spectroscopic methods, such as near infrared and Raman spectroscopies, are responding 
this challenge and their utilisation has increased a lot during the past few years. The 
methods are fast, they do not demand sample preparation, both qualitative and 
quantitative information from chemical and physical properties of the sample can be 
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retrieved at real-time. All this can be gained with only one measurement! However, 
spectroscopic methods demand multivariate data analysing methods, in order to 
systematically differentiate the useful information. Multivariate methods can reveal 
information about interactions and correlations between variables and between variables 
and observations (Eriksson et al., 2001). Spectroscopic and other real-time monitoring 
methods can be attached to all of the unit processes in pharmaceutical powder 
technologies described in Figure 1.  
 
 
Figure 1. The unit processes of manufacturing of tablets. The arrows represent the unit processes which 
were studied in this thesis. Analysing methods are marked with grey. 
 
The whole processing cycle demands attention to enhance the quality of final products. In 
this thesis means for real-time monitoring were developed for three different unit 
processes: mixing, drying and tabletting. Real-time monitoring methods can be 
implemented also to other unit processes. The methods increase the knowledge of the 
critical parameters in the processes and the phenomena occurring during operations. In 
addition, amount of waste would decrease substantially if powder behaviour would be 
known better and the changing circumstances could be responded at real-time. In the best 
case they can even increase process understanding. Process understanding can be a 
foundation for innovation and continuous improvement in pharmaceutical development 
and manufacturing. New, fast and accurate methods are craved for to increase the quality 
and safety of the final products faster and more efficiently than ever before. However, 
one cannot forget the importance of traditional parameters such as temperature, pressure 
and moisture even if new methods are established for real-time monitoring. 
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2. Literature review 
2.1 Pharmaceutical powders 
A large proportion of pharmaceutical products consist of powdered material. Therefore 
there is a great deal of interest to study the behaviour of solids and acknowledge the 
importance of these properties.  
  
A powder is a heterogeneous system of dry solid particles and air. The maximum particle 
size in a material classified as a powder is less than 1000 µm (Staniforth and Aulton, 
2007). Powders behave partly as liquids and partly as solids; they can flow like liquid and 
fragment as a solid. Powders can be electrostatic especially in dry conditions. This can 
induce challenges for powder processing in pharmaceutical industry because particles are 
sticking to each other and walls of the handling chambers. Pharmaceutical powders are 
usually organic materials and they are used as mixtures. Most commonly powders are 
compressed to tablets or capsulated.  
 
Powders can be granulated to increase the particle size before other processing. 
Granulation increases flowability, makes particle size uniform, reduces dust and can even 
control the rate of drug release and improve compression characteristics. By definition  
a granule has a specified particle size of 2–4 mm (Summers, 2007). In practise, even 
smaller particles than 2 mm can be said granules too. Granules are not as electrostatic as 
powders and they are much easier to handle.  
2.2 Mixing of powders 
Mixing is defined as a process that tends to result in a randomisation of dissimilar 
particles within a system (Rippie, 1970). Mixing is a crucial but complex process for 
manufacturing of solid dosage forms. Many variables, such as the characteristics of the 
solid or of the mixer type, and the operation conditions, can influence the degree of 
mixing (Fan et al., 1970). This explains why optimum operation conditions are unique to 
every product (Sindel et al., 1998).  
 
Mixing has been the target of research for decades. Poux et al. (1991) studied various 
kinds of mixers. Johnson (1975) investigated the influence of powder characteristics such 
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as particle size and size distribution on the segregation of mixtures. Speiser and Tawashi 
(1962) attempted to determine how various type of mixers influence the mixing time and 
the homogeneity of a mixture.  
 
The uniformity of mixture has been controlled by assembling samples from the 
processing mass at different stages. Sampling has been a major problem in the mixing 
studies. It has been challenging to obtain representative sample from the container. When 
any kind of probe or thief sampler is pushed in the mass it will affect the mass. The API 
content of these samples has been determined with chromatographic or ultraviolet-Visible 
(UV-Vis) spectroscopic methods (Wargo and Drennen, 1996). Conventional operations 
are time consuming and laborious. Recently, spectroscopic methods have been coupled 
with mixing. Especially near infrared spectroscopy (NIRS) is overtaking previous 
methods because of its advantages.  
2.3 Fluid bed drying 
The temperature is raised in many pharmaceutical processes such as wet granulation, 
drying and tabletting processes. Increase of the temperature can accelerate hydrolysis and 
oxidation reactions dramatically (Florence and Attwood, 2006). In addition, thermal 
stress that pharmaceutical solids are exposed to during manufacturing can induce various 
processing-induced phase transitions in bulk drug APIs and/or excipients (Miroshnyk  
et al., 2006). Because drying is one of the standard unit operations in the pharmaceutical 
industry, that typically involve raised temperature, it is important to understand the 
transitions that may take place upon exposure of pharmaceutical solids to thermal stress. 
For these reasons the formulation of heat sensitive APIs is a challenge for the 
pharmaceutical industry.  
 
Fluid bed drying is a common method to dry pharmaceutical materials. The contact 
between the drying gas (usually air) and the particles is good which leads to fast heat 
transform and drying (Rankell et al., 1986). The parameters such as moisture or the speed 
of the inlet air can be optimised during the process. The material can flow in many 
different ways during the fluid bed drying. The fluidisation type is dependent on the 
material properties for example its density, triboelectricity and particle size. There are 
also challenges in fluid bed drying. The movement of the air and therefore the heat 
transfer is yet unsolved.   
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2.4 Tabletting 
European Pharmacopoeia (2005) defines tablets as: ”solid preparations each containing a 
single dose of one or more active substances and usually obtained by compressing 
uniform volumes of particles. Tablets are intended for oral administration.” A tablet 
should posses following attributes: 1) ability to stand mechanical treatment such as 
production and packaging, 2) it should not have faults such as cracks and discoloration, 
3) it should have desired chemical, physical and microbiological stability, and  
4) it should release the drug in a reproducible and predicted manner (Gunsel et al., 1970).  
 
Tablets are the most common pharmaceutical dosage form (Alderborn, 2007). They have 
many advantages such as ease of handling, good patience compliance, they are relatively 
easy and inexpensive to manufacture, safe to administrate and they are really versatile. 
Compression process includes several phases (Train, 1957; Duberg and Nyström, 1986) 
(Fig. 2): A) filling of the die, B) rearrangement of particles, C) elastic or plastic 
transformation of particles (Krycer and Pope, 1982), D) fragmentation, E) rearrangement 
of fragments, F) elastic or plastic transformation of fragments (Duberg and Nyström, 
1986) and G) formation of bonds. Phases from D to F can occur several times during 
compression. The elastic and plastic transformation and fragmentation of particle is 
presented in Figure 3. 
 
Figure 2. Compression of particles. A. The die has been filled, B. Rearrangement of particles, C. Elastic or 
plastic transformation of particles, D. Fragmentation, E. Rearrangement of fragments, F. Elastic or plastic 
transformation of fragments, G. Formation of bonds (magnification from the figure F.). The arrow 
represents compression force. 
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Tablet machines can be equipped to measure punch forces and displacements. This 
enables real-time monitoring of the compression process. However, the compression data 
has usually been evaluated by studying compression force profile for single tablet 
(Marshall, 1989; Hoblitzell and Rhodes, 1990; Schmidt and Vogel, 1994; Yliruusi et al., 
1997; Nicklasson and Alderborn 2000; Palmieri et al., 2005; Patel et al., 2007). Force, 
time, and displacement curves have broadly been studied to get information of 
compaction properties of pharmaceutical materials. Equations, such as Heckel, Kawakita 
and Cooper-Eaton, have been generated to describe force profiles (Heckel, 1961; Cooper 
and Eaton, 1962; Kawakita and Lüdde, 1970/1971).  
 
 
 
Figure 3. Transformation of particles during compression. 
2.4.1 Effect of particle size on tabletting 
The role of initial particle size in the compression process was already recognised in the 
1950s (Hersey et al., 1967). Control of particle size and size distribution is important 
because they influence the flowability (Fan et al., 2005; Li, 2008; Deanne and Etzler, 
2009), tablettability (Sun and Himmelspach, 2006), content uniformity (Yalkowsky and 
Bolton, 1990; Rohrs et al., 2006), tablet weight variation (Laitinen et al., 2004; Fan et al., 
2005), tensile strength of tablet (Olsson and Nyström., 2001), drug release (Heng et al., 
2001) and dissolution properties of tablets (Carless and Sheak, 1975; Jillavenkatesa et al., 
2002; Yu, 2008; Deanne and Etzler, 2009). 
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The effect of particle size on flowability has been widely studied, but the results are often 
contradictory depending the original particle size and size distribution. Fan and 
coworkers (2005) noted that flowability was improved with larger particles and narrower 
particle size distribution. However, there is an increase in flowability as the size of 
granules decreases in some cases (Jillavenkatesa et al., 2002). Nevertheless, when the 
particle size was reduced even more the flowability decreased. This can be explained 
with changes in forces which influence the flow. As particle size decreases, several 
interparticulate forces such as mechanical interlocking, hydrogen bonding, electrostatic, 
and van der Waals forces can predominate over gravity (Marks and Sciarra, 1968). These 
forces act in the surface of the particles and smaller particles have larger surface area in 
relation to their mass than larger ones. In addition, these varying results may be due to 
differences in the flowability measurement set-ups, humidity of the air, and/or particle 
properties such as original particle size.  
 
The particle rearrangement during compaction is affected by the particle size and size 
distribution (Patel et al., 2006). The smaller particles can enter into the voids between the 
larger particles therefore a closer packing arrangement is obtained during the tabletting 
process. The particle surface area capable of forming interparticulate bonding is increased 
when particle size is decreased (Nyström et al., 1993; Fichtner et al., 2008). For most 
pharmaceutical powders, compaction of smaller particles results in stronger tablets 
because they have larger surface area for bond formation (Hersey et al., 1967; Yajima et 
al., 1996; Sun and Grant, 2001ab; Fichtner et al., 2005; Patel et al., 2006; Lee and Kuo, 
2006). The initial particle size can affect both the number and the bonding force of the 
interparticulate bonds (Eriksson and Alderborn, 1995). However, fragmentation of larger 
particles can equalise the particle size and reduce the influence of size difference (Sun 
and Grant, 2001a). Particle size plays a crucial role in the tensile strength of tablets 
especially when compressing materials that form solid bridges (such as sodium chloride) 
during compaction (Adolfsson et al., 1999). In addition, particle size enlargement causes 
reduction in tablettability of microcrystalline cellulose (MCC) powders, according to Sun 
and Himmelspach (2006).  
 
The particle size distribution of granules during tabletting has not previously been studied 
using intact granules or tablets. For example Carless and Sheak (1975) and Khan and 
Rhodes (1975) have used broken tablets after tabletting process.  
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2.4.2 Segregation during tabletting 
Reliable and uninterrupted flow of uniformly mixed material is crucial for manufacturing 
high quality tablets. Segregation can cause weight variation in tablets and therefore 
quality problems for the final dosage form. Segregation of powders can occur as a result 
of differences in the physical and mechanical properties of the particles. If the 
segregation phenomenon occurs due to the sifting mechanism, in which smaller particles 
move through a matrix of larger particles, changing the particle size ratios of the 
components to within 1.3:1 or decreasing the mean particle size below 100 µm will 
reduce sifting segregation (Carson, 1988; Prescott and Hossfeld, 1994). Granule 
segregation can eventually cause weight variation in tablets and therefore quality 
challenges for the final dosage form. Antikainen and others (2006) found a distinct trend 
between segregation tendency and weight variation in tablets when they used a single 
punch tabletting machine. In general, segregation tendency increases with the particle 
size (Xie et al., 2008). Segregation is more likely to occur in wide size distributions than 
in narrow size distributions. When the size of the granules is similar, segregation does not 
occur and there is no significant change in the drug content of tablets. 
2.5 Tablet properties 
2.5.1 Mechanical strength of tablets 
The mechanical strength of a tablet provides a measure of the bonding potential of the 
material. It means the ability of tablet to resist breakdown or the force which is needed to 
break the tablet (European Pharmacopoeia, 2005). Tablets must remain intact until 
administration. However, they must be soft enough so that the active pharmaceutical 
ingredient can be released in the alimentary tract.  
 
The factors that influence the mechanical strength of tablets can be divided into three 
groups: 1) material and formulation factors, 2) process factors, and 3) environmental 
factors. Formulation factors are due to the physical and chemical properties of particles. 
A process factor may include the equipment used and environmental factors the relative 
humidity (RH) and temperature of the air. In pharmaceutical systems interparticular 
interactions, triboelectricity, liquid and solid bridges, porosity, particle size and shape, 
and wetting may also be essential with regard to the mechanical strength of granular 
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systems (Alderborn and Nyström, 1996). In addition, the size and shape of the tablet 
influence the mechanical strength.  
 
The mechanical properties of pharmaceutical tablets can be divided to friability and 
hardness or crushing strength of tablets. Friability testing is designed to evaluate the 
ability of the tablet to withstand abrasion in packaging, handling and shipping. The 
weight loss due to abrasion is a measure of the tablet friability. The term crushing 
strength and hardness of the tablet are used in a disorganised manner in the literature. 
Usually crushing strength means the force that is needed to break the tablet by diametral 
compression (Fig. 4). Tensile strength is an extension for crushing strength. It takes the 
dimension of the tablet into account on the contrary to crushing strength. However, if one 
wants to reliably compare the strength of the tablets, only tablets with the same 
dimensions and other attributes, such as material and density, can be compared to each 
other. The measuring method, friability or strength, must be chosen depending on subject 
of interest.  
 
 
Figure 4. Diametral compression of a tablet. 
 
The mechanical strength of tablets can be tested in many ways (Alderborn, 2007). The 
method most used in pharmaceutical technology is the diametral compression test 
(Davies et al., 2007). Testing the mechanical strength of tablets with a conventional 
indirect diametral hardness-testing apparatus is an invasive and laborious method that 
breaks up the tablet. Recently, new nondestructive methods such as vibrational 
spectroscopic techniques have been introduced in the field of pharmaceutical powder 
technology. 
2.5.2 Surface properties of tablets  
The scanning electron microscope (SEM) and non-contact laser profilometry (LP) can 
been used to investigate surface properties of granules and tablets. Riippi and coworkers 
(1998) examined the effect of compression force on surface structure and tablet 
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parameters, such as crushing strength and friability. They discovered that the surface 
roughness parameters characterise the tablet surface quite well and noted that the 
crushing strength of the tablets, as well as the surface smoothness, increased with 
compression force. In addition, Seitavuopio and coworkers (2003) came to the same 
conclusion that higher compression pressure leads to smoother tablet surfaces. Podczeck 
and others (1999) investigated tablets of five different compression formulations for their 
surface roughness, using SEM and LP. They found that the composition of a formulation 
not only influenced the tabletting properties of the powder mixtures, but also the surface 
properties of the final product. An increase in tabletting pressure reduced the tablet 
surface roughness.  
2.5.3 Weight variation of tablets 
The weight variation of tablets is an important factor because if the weight changes also 
the content uniformity changes. The weight variation in tablets decreases with decrease in 
granule size according to Marks and Sciarra (1968). They suggested that when the size of 
the granules became smaller there was a greater loss of weight due to the friability of the 
granules. Laitinen and coworkers (2004) concluded that granules which size fraction was 
0.25-0.50 µm filled the tabletting die efficiently and had small weight variation in tablets. 
Fan and coworkers (2005) noted that blends with good flowability have low tablet weight 
variation and good content uniformity. Spring (1977) noticed that the variation was 
greatest at the beginning and end of tabletting process and it decreased with decreasing 
granule size. In general, issues that influence bulk density can affect tablet weight, 
because the weight of tablets is dependent on the packing conditions in the die (Ridgway 
and Williams, 1977).  
2.6 Colour analysis 
The colour can be measured quantitatively either by a spectrophotometer or  
a colorimeter. The tristimulus method measures the light reflected from the object using 
three sensors filtered to have the same sensitivity as the human eye (Ohno, 2000). 
Tristimulus values are amounts of the three main colour stimulus. According to the 
Commission Internationale de l'Eclairage, International Commission on Illumination 
(CIE) 1931 standard tristimulus values are called X, Y and Z values. Tristimulus 
colorimeter directly measures these tristimulus values and they can be used to calculate 
values in L*a*b* colour space. L*a*b* colour space is a colour-opponent space based on 
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nonlinearly-compressed CIE XYZ colour space coordinates (CIELAB). The image is 
divided into three components: L*, a* and b*. L* component describes the lightness and 
it is similar to black-and-white images, a* component describes colour tones from green 
to red and b* component colour tones from blue to yellow. L*a*b* colour space is 
displayed as a figure in study IV.  
In addition to L*a*b* colour space also RGB (red, green, blue) and CMYK (cyan, 
magenta, yellow, key black) colour spaces are widely used. The main purpose of the 
RGB colour model is to display images in electronic systems, such as televisions and 
computers. The CMYK colour model, referred to as process colour, is used in colour 
printing. 
2.6.1 Colorimetric studies 
Some colorimetric studies have been made in the field of pharmaceutical technology. 
Siddiqui and Nazzal (2007) conclude that there is a correlation between the surface 
colour and tensile strength of tablets and colour measurement could be in use to detect 
deviations in tablet hardness. Chan and coworkers (2001) measured colour distribution on 
the film coat using tristimulus colorimeter. Surface colour of tablets has also been studied 
by Bogdansky (1975) with tristimulus colorimeter. Oram and Strine (2006) identified key 
process parameters of a drug using colour measurement. Berberich and coworkers (2002) 
studied the whiteness of uncoated tablets during storage. Also the surface coverage of 
coarse particles which were coated with coloured or uncoloured stearic acid has been 
studied (Gren and Nyström, 1991).  
2.6.2 Heat indicator materials 
The heat indicator materials are thermochromic which means that they change their 
colour at the specific temperature. The indicators used in this thesis were ChromaZone® 
indicators that are coloured until the specific temperature where they change into 
colourless or light (ChromaZone, 2010). The colour change is reversible because the 
colour returns when the temperature is decreased. More specific description of the 
indicator materials is introduced in study IV. 
 
ChromaZone® materials have been used for example in labels, packaging and textile. 
They can also be used in coatings on plastics, ceramics or glassware. Thermochromic 
indicators have not formerly been used as a thermal indicator in pharmaceutical unit 
Literature review 
  
12 
processes. However these kinds of indicators could create new possibilities for 
visualising process at real-time. The indicator could be mixed into processed mass and 
the colour change of the mass could be observed during the operation. The colour change 
would indicate that the conditions are too hot for the heat sensitive API.  
2.7 Vibrational spectroscopy 
Currently, the quality tests related to the unit processes mostly are performed off line, i.e. 
removing the sample from manufacturing site, after preparing collected samples for 
analysis. During sample preparation, other valuable information pertaining to the 
formulation matrix is often lost (US Food and Drug Administration (FDA), 2004). 
Several new technologies are now available that can acquire information with minimal or 
no sample preparation. Thus the process analytical technology (PAT) initiative of the 
FDA encourages the use of NIRS or similar analytical techniques for reducing production 
cycle times (FDA, 2004). With NIR and Raman spectroscopy it is possible to 
noninvasively and simultaneously analyse multiple attributes present in matrix, obtain 
quantitative and qualitative information on both the chemical and physical properties of 
sample. This eliminates the waiting period for laboratory results at the end of each unit 
operation (Gupta et al., 2005). It also provides the continuous real-time quality assurance 
as suggested by the FDA in the PAT initiative. In addition, spectroscopic methods may 
provide significant advances as a future process analytical tool, since spectra can be 
measured directly on the surfaces of nondestructed samples (i.e. tablets) without any 
pretreatment (Otsuka and Yamane, 2006). In addition, they can be used almost 
everywhere and the spectroscopic devices can be portable. The methods are easy to use 
and the measurements are repeatable.  
2.7.1 Near infrared spectroscopy 
Theory 
NIRS is a spectroscopic method utilising the near infrared region of the electromagnetic 
spectrum (780―2500 nm or 12821―4000 cm-1) (Burns and Ciurczak, 2001). The NIR 
spectra consist of overtones and combination bands of the fundamental molecular 
absorptions of polar groups such as O-H, N-H, S-H and C=O bonds (Siesler et al., 2002). 
The important molecules for NIR measurements have most often been water  
(O-H stretch), proteins, carbohydrates, fats, and hydrocarbon classes including 
pharmaceuticals. The molecular overtone and combination bands seen in the NIR are 
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typically very broad, leading to complex spectra; it can be difficult to assign specific 
features to specific chemical components. Multivariate analysis techniques are usually 
needed to extract the desired chemical information. Careful development of a set of 
calibration samples and application of multivariate calibration techniques is essential for 
NIR analytical methods.  
 
NIRS follows the Lambert-Beer law: 
 
abcA
I
I
Log ==0 ,       (Eq. 1) 
 
where    I0 is the intensity of the incident light 
   I is the intensity measured after passing through the sample 
   A is absorbance 
   a is the absorption coefficient or the molar absorptivity 
   b is the path length 
   c is the concentration of the absorbing material. 
 
Since there is a direct and linear relationship between sample concentration, path length 
and the absorbance of light at a particular wavelength, the measuring set-up is crucial for 
accurate measurements.  
 
Instrumentation for NIRS includes a light source, a detector, and a dispersive element  
(a prism, or more commonly a diffraction grating) to allow the intensity at different 
wavelengths to be recorded. The type of detector used depends primarily on the range of 
wavelengths to be measured. Silicon-based CCDs are suitable for the shorter end of the 
NIR range, but are not sufficiently sensitive over most of the range. InGaAs and PbS 
devices are more suitable. Depending on the sample, the spectrum can be measured in 
transmission, transflection or reflection mode. 
Pharmaceutical applications 
One advantage is that NIRS can typically penetrate much deeper into a sample compared 
to mid infrared radiation. NIRS is therefore not a sensitive technique, but it can be very 
useful in measuring bulk material with little or no sample preparation. Physical properties 
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of the sample can also affect the reflected light and interfere with the chemical 
information of the spectra. This complicates especially quantitative measurements. 
However, the phenomenon can be utilised to determine physical properties, such as 
particle size, and density or crushing strength of the sample. However, physical 
measurement requires well-established measurement methods.  
 
The most important benefits of NIRS are that the samples require no preprocessing and 
real-time information is gained from the process. Unlike conventional methods of 
analysis, NIRS is very fast, noninvasive, provides information about physical and 
chemical properties of the sample and it can be used in line, at line and on line 
measurements. NIRS can be used for the qualitative analysis as well as for the 
quantitative analysis of powders (Siesler et al., 2002). It is very sensitive for water, which 
enables the determination of the water content.  
 
Typical applications for NIRS include pharmaceutical, medical diagnostics, food and 
agrochemical quality control. The basic uses for NIRS have been process control, quality 
assessment, identification of raw materials and process byproducts, and chemical 
quantitative analysis of complex mixtures. NIRS is a valuable measurement technique for 
use in continuous or real-time process monitoring. NIRS is described in the European 
Pharmacopoeia (chapter 2.2.40) and in the US Pharmacopoeia general chapter (1119). 
NIRS have been used in pharmaceutical field in moisture, polymorph, crystallinity, and 
API content determination (Roggo et al., 2007). The crushing strength of tablets has also 
been investigated with NIRS (Morisseau, 1996; Morisseau and Rhodes, 1997; Ebube et 
al., 1999; Kirsch and Drennen, 1999; Chen et al., 2001; Donoso et al., 2003; Otsuka and 
Yamane, 2006). In addition it has been utilised in monitoring of freeze drying, 
granulation, drying, coating and mixing processes. Ciurczak (1991) investigated the 
homogeneity of mixtures off line. Sekulic et al. (1996) and El-Hagrasy et al. (2001) 
studied powder blend homogeneity. Blanco et al. (2004) and Filho et al. (2004) 
acquainted themselves with strategies for constructing a calibration set for quantitative 
NIRS measurements. Berntsson et al. (2002) monitored in line powder blending by near 
infrared reflection spectroscopy and Patel et al. (2000) quantified polymorphs in 
mixtures. Rantanen et al. (2005a) used chemometrics in order to specify the factors 
influencing the quantification of anhydrate/hydrate powder mixtures. Chemometrics has 
also been used in a study conducted by Li and Worosila (2005) when the quantification 
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of powder mixtures using at line NIRS was performed. Other studies have used NIRS 
with a fibre-optic probe. The first reported study on powder mixtures with a fibre-optic 
probe was conducted by Kaye et al. (1969). More recently, Li et al. (2006) studied the 
mass-balanced blend uniformity of pharmaceutical powders with a fibre-optic probe as 
well as Storme-Paris with coworkers (2009) and Wu and Khan (2009). Benedetti’s study 
concerning powder flow characterisation with in line NIRS also used a probe (Benedetti 
et al., 2007). Finally, NIRS has also been attached to the mixer by Liew and coworkers 
(2010). They quantified cohesive powders in a bin blender and used PLS as analysis 
method.  
2.7.2 Raman spectroscopy 
Theory 
The Raman effect occurs when light interacts with the electron cloud of the bonds  
(i.e. the electric dipole) of the molecule (McCreery, 2000). When light is scattered from  
a molecule most photons are elastically scattered. These scattered photons have the same 
energy and, therefore, wavelength, as the incident photons. However, a small fraction of 
light, approximately one of the million photons, is scattered at optical frequencies 
different from the frequency of the incident photons (Vankeirsbilck et al., 2002). The 
process leading to this inelastic scatter is the termed the Raman effect.  
Sir Chandrasekhara Venkata Raman received a Nobel Prize in Physics concerning Raman 
effect in 1930. 
 
The incident photon excites one of the electrons into a virtual state. For the spontaneous 
Raman effect, the molecule will be excited from the ground state to a virtual energy state, 
and relax into a vibrational excited state, and which generates Stokes Raman scattering 
(McCreery, 2000). However, a small fraction of the molecules are in vibrationally excited 
states and they are relaxed back to the ground state. The scattered photon appears at 
higher energy, as shown in Figure 5. This anti-Stokes Raman spectrum is always weaker 
than the Stokes-shifted spectrum. The Stokes and anti-Stokes spectra contain the same 
frequency information.  
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Figure 5. Vibrational energy state diagram for Raman and NIR spectroscopy. (Adapted from Siesler et al., 
2002.) E is excitation energy, v is vibrational quantum number, q is vibrational coordinate, v = 0 is ground 
state, v = 1, v = 2, etc. are excited states.  
 
Raman scattering occurs because a molecular vibration can change the polarisability of 
the molecule (McCreery, 2000). The polarisability measures the ease with which the 
electron cloud around a molecule can be distorted. A molecular polarisability change is 
required for the molecule to exhibit the Raman effect. In other words symmetric 
vibrations of non-polar groups are Raman active. The vibrations of a highly polar moiety, 
such as the O-H bond, are usually weak. Typical strong Raman scatterers are moieties 
with distributed electron clouds, such as carbon-carbon double bonds. Bending or 
stretching the bond changes the distribution of electron density substantially, and causes  
a large change in induced dipole moment.  
 
Typically, a sample is illuminated with a laser beam. Light from the illuminated spot is 
collected with a lens and sent through a monochromator. Wavelengths close to the laser 
line (due to elastic Rayleigh scattering) are filtered out and those in a certain spectral 
window away from the laser line are dispersed onto a detector, usually a CCD camera.  
Pharmaceutical applications 
Raman spectroscopy is commonly used in chemistry, since vibrational information is 
very specific for the chemical bonds in molecules. It therefore provides a fingerprint by 
which the molecule can be identified. Vibrational Raman spectroscopy is not limited to 
intramolecular vibrations. Crystal lattice vibrations and other motions of extended solids 
are Raman-active. In addition to chemical applications Raman spectroscopy can also be 
used for physical measurements. The disadvantages of Raman spectroscopy are the 
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weakness of the signal, warming of the sample caused by the laser and the fluorescence 
phenomenon. However, the weakness of the signal can also be used as an advantage, 
since it enables measurement directly from the sample with no preprocessing. The 
fluorescence can be problematic, even when the measurement conditions are in order. 
Fortunately, fluorescence is not a problem for most APIs. 
 
Quantitative measurement with Raman spectroscopy is possible because signal intensity 
is directly proportional with the concentration. Correlation between signal and 
concentration enables straightforward concentration measurements and explains why 
Raman spectroscopy has been used in many pharmaceutical processes, even in real-time 
applications (Rantanen, 2007). Nevertheless, the number of physical measurements, such 
as crushing strength of tablets, is limited in the literature. Some studies determined 
influence of particle size on Raman intensity (Pellow-Jarman et al., 1996; Fangxin et al., 
1997; Wang et al., 2002; Williams et al., 2004; Hu et al., 2006). The results showed that 
the intensity of the signal changes with change in particle size. The particle shape and 
solid state form of the material measured, as well as the wavelength of the signal and 
finally temperature, also influence the signal intensity. 
 
Few reports are available on the applicability of Raman spectroscopy for tablet hardness 
determination. Only Wang’s (2002) and Johansson’s (2005) groups studied intact tablets 
and Picker-Freyer and Schmidt (2004) studied broken tablets. Picker-Freyer and Schmidt 
observed differences in the Raman spectra that were due to structural changes in the 
tablet. The intensity of the spectra increased with increase in the hardness of the tablets. 
Johansson et al. (2005) compressed tablets with different compression forces and noted 
no significant effect of tablet density on the Raman signal. They also stressed that the 
results were based on measurements of a single type of tablet, so these results cannot be 
generalized for all types of tablets. Wang and coworkers (2002) investigated the effects 
of compression force during tabletting on the Raman signal. They studied the effect of 
the tablet thickness by comparing the Raman signals for tablets of the same particle-size 
powder. In their measurement the Raman intensity decreased with increasing 
compression force until a constant density was achieved.  
 
Raman and NIR spectroscopy are complimentary methods. They both can be utilised in 
the same processes and they can give information from the same phenomena but from 
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different point of view. In general NIRS can be faster and more water-sensitive than 
Raman spectroscopy. However, Raman has sharper peaks and it can be utilised 
measurements from aqueous systems, because water does not disturb it. The selection of 
method has to be done according to the attribute studied based on previous knowledge. 
Sometimes both of the methods can give the same information but most of the time one 
or the other is more convenient.  
2.8 Data analysis and modelling 
Extracting useful information from massive amount of data is a challenge when using 
spectroscopic methods. This procedure can involve multiple phases before actual analysis 
(Fig. 6.) and it demands knowledge and carefulness to succeed. In the next chapter 
scaling, spectra pretreatment and modelling are discussed. In addition spectral region 
used in the analysis can have significant affect to results. 
 
 
 
Figure 6. Preprocessing of the data illustrated as a flow chart. 
 
2.8.1 Scaling 
Variables can have substantially different numerical values. Typically, a variable with  
a large range has a large variance and variable with a small range has a small variance. 
Thus, some kind of data scaling is mandatory when variables are of different type and 
their values are at different scales and units. There is always a risk present when scaling 
the data. Thus scaling, and other pretreatments, has to be performed with careful manner 
(Gabrielsson et al., 2006). The correct pretreatment methods have to be chosen according 
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to prior knowledge of the variables. Only if scaling is performed correctly it can lead to 
reliable results. 
 
In general, if variables are all on the same scale such as spectroscopic data in chemical 
analysis then centering is usually recommended scaling method. If the variables are on 
different scales (for instance weight and length) the unit variance (UV) scaling is 
recommended. 
Unit variance scaling 
UV scaling is used to emphasise small variations in the data by giving all values equal 
weighting. The standard deviation (SD) is calculated for each variable and the scaling 
weight as the inverse SD is obtained. Subsequently, each variable is multiplied by inverse 
SD. Each scaled variable then has equal (unit) variance. UV scaling does not change the 
mean values of the variables (Eriksson et al., 2001). However, UV scaling has a risk of 
scaling up noisy variables.  
Mean centering 
In mean centering the average value of each variable is calculated and then subtracted 
from the data. This leads to the fact that the mean value for every variable is zero. By 
removing the average from the data, the differences between the samples are substantially 
enhanced in terms of both concentration and spectral response. This usually leads to 
calibration models that give more accurate predictions. Mean centering removes constant 
background contributions, which usually are of no interest for data variance 
interpretation.  
 
Mean centering is often used for spectroscopic data when analysing chemical properties 
such as content uniformity. When applying mean centering there is a risk of losing 
relevant information which is hidden in the noise (Gabrielsson et al, 2006).  
2.8.2 Pretreatments 
Spectra of powders typically display a scattering variation, due to the physical properties, 
such as particle size of the sample. This can induce variations of the optical path length. 
Sometimes the scattering can even be a superior contributor to the spectrum, accounting 
for most of the variance in the data. The scattering is not uniform throughout the 
spectrum. Typically, this appears as a baseline shift, tilt and sometimes curvature, where 
Literature review 
  
20 
the degree of influence is more pronounced at the longer wavelength end of the spectrum. 
That is why a well defined sample analysis preparation protocol is required.  
 
The aim of the spectroscopic data preprocessing is to remove these unwanted systematic 
variations, such as baseline shift. The most current data pretreatments are the 
normalisation methods like standard normal variate (SNV) and multiplicative scatter 
correction (MSC), the derivative methods (for example the Savitzky-Golay method) and 
the orthogonal signal correction (Roggo et al., 2007). 
 
SNV correction is designed to remove the large amount of variability that may be caused 
by scattering effects from reflectance spectra (Fearn et al, 2009). It corrects for 
differences in spectroscopic path lengths or multiplicative variations induced by 
scattering effect. SNV correction centres each spectrum to zero intensity by subtracting 
the average of all the spectral responses in the vector from each of the original values. 
Finally, each spectrum is divided by its SD (Barnes et al., 1989). The SNV method is 
performed on one spectrum at a time, and does not require the use of a reference 
spectrum. It has been used successfully with NIRS data (Fearn et al, 2009). However, the 
use of SNV for some quantitative measurements is questionable because the correction 
can alter the peak intensities.  
 
The preprocessing of spectra to determinate amorphous content of lactose has been 
studied by Savolainen and coworkers (2007). They compared the effect of scaling and 
pretreatment methods. In addition Candolfi and coworkers (1999) and Blanco and others 
(1997) studied the effect of preprocessing to NIR spectra. 
2.8.3 Modelling 
Principal component analysis 
Principal component analysis (PCA) is a multivariate projection method designed to 
extract and display the systematic variation in a data matrix. Hence PCA is used for over 
viewing and classifying data and detecting trends (Wold et al., 1987). It can also be used 
to detect outliers.  
 
The starting point for PCA is a matrix of data with N rows (observations) and K columns 
(variables). The observations can be process time points, batches from a process etc. In 
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order to characterise the properties of the observations variables are measured. These 
variables can be for instance of spectral origin (NIR, Raman) or measurements from 
sensors such as temperature. PCA can uncover the relationships between observation and 
variables, and among variables themselves. PCA derives a model that fits the data as well 
as possible in the least squares sense. It can be said that PCA displays systematic 
variation in the data matrix describing the variation with minimum amount of variables 
(Gabrielsson et al., 2002).  
 
PCA creates score and loading plots. Scores provide information about similarities and 
differences in the spectra. Loadings explain the origin of scores, so they have  
a relationship to the original data (Eriksson et al., 2001). Prior to PCA, data is often 
pretreated in order to transform the data into a form suitable for analysis. Preprocessing 
can make the difference between useful model and no model at all (Eriksson et al., 2001).  
Partial least squares regression 
Partial least squares (PLS) regression (Wold, 1966; Wold et al., 1983) combines features 
of PCA and multiple linear regression in order to create a model between variables (X, 
for instance spectra) and property of interests (Y, for instance concentration) (Eriksson et 
al., 2001; Roy and Roy, 2008). It provides a reduced solution, which is statistically more 
robust than multiple linear regression and is useful when a large number of cross-
correlated and/or noisy predictor variables are present (Beebe et al., 1998; Roy and Roy, 
2008). PLS compresses the size of the spectra and removes insignificant information. 
 
PLS creates latent variables and weights that provide information about the correlation 
between the variables and similarities/dissimilarities among the compounds. In other 
words PLS reveals how the spectra and for instance concentration are related. In its 
general form, PLS maximises the covariance between different sets of variables. PLS 
modelling can be used to obtain qualitative and quantitative information from spectra that 
are usually difficult to obtain using traditional univariate methods. It has become  
a standard tool for processing a wide spectrum of chemical data problems.  
2.9 Process analytical technology 
The concept of PAT has been introduced to improve our understanding of the 
pharmaceutical process and to monitor and control critical process parameters (FDA, 
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2004). It was originally based on process analytical chemistry which is  
a multidisciplinary field that encompasses a combination of analytical chemistry, process 
engineering, process chemistry, and multivariate data analysis. Nowadays the view of 
FDA is that the quality cannot be tested into products; it should be designed beforehand. 
Thus PAT has emphasised the importance of evaluating not only the final product but the 
whole production process. In addition, the aim is real-time quality assurance and  
a capability of process control.  
 
Product and process development on a small scale and on or in line process monitoring to 
collect data in real-time can provide increased understanding for process development, 
and control. A process is well understood when all critical sources of variability are 
identified and explained, and variability is managed in the process. Process monitoring 
and control strategies are intended to monitor the state of a process and actively 
manipulate it to maintain a desired state. Optimisation of manufacturing processes 
includes designing a process measurement system which allow real-time or near real-time 
monitoring of critical attributes. 
2.10 Real-time monitoring 
The physical state of a process is derived from measured variables, for instance 
temperature and pressure. When monitoring these variables using traditional approaches 
usually only one variable can be observed at the time. However, the state of process is 
usually determined by several factors. There can be interactions between the variables, 
but they are not detected when using a univariate approach (Kourti and MacGregor, 
1995). Nowadays chemometric methods enable multivariate approach to data analysis. 
This is really needed because the amount of data generated is increasing due to new 
process analysing techniques, such as spectroscopic methods. 
 
Spectroscopic methods provide nondestructive measurements that contain information 
related to physical and chemical attributes of the materials. These measurements can be 
performed: 1) at line: Measurement where the sample is removed, isolated from, and 
analysed in close proximity to the process stream. 2) on line: Measurement where the 
sample is diverted from the manufacturing process, and may be returned to the process 
stream. 3) in line: Measurement where the sample is not removed from the process 
stream and can be invasive or noninvasive. 
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These techniques make real-time control and quality assurance during manufacturing 
possible. Simultaneous monitoring of both chemical and physical properties can lead to 
learning the important process variables and improved process understanding. This leads 
to possibility to control the process. 
2.10.1 Near infrared spectroscopy as real-time monitoring tool 
 
NIRS has been widely studied as real-time monitoring tool in pharmaceutical powder 
technology (Bakeev, 2006). NIRS has been used as a PAT tool (Cogdill et al., 2004).  
Cogdill and coworkers (2005a, b, c) developed and validated a PAT method using NIRS 
for the on line prediction of intact tablet hardness and active pharmaceutical ingredient 
(API) content. In addition, real-time NIR monitoring of moisture in fluidised bed drying 
has been studied (Rantanen et al., 1998; Rantanen et al., 2000ab; Morris et al., 2000; 
Wildfong et al., 2002; Jørgensen et al., 2002; Rantanen et al., 2005a). Harris and Walker 
(2000) studied also drying and Rantanen and others (2005b) investigated the high shear 
granulation. In addition tensile strength measurements using NIRS during roller 
compaction has also been reported (Gupta et al, 2004). Also intact paracetamol tablets 
have been assayed using NIRS (Trafford et al., 1999). Mixing operation has been broadly 
studied using NIRS for years (Sekulic et al., 1996; Hailey et al., 1996; Lai et al., 2001; 
El-Hagrasy et al., 2005a,b,c) as well as flowability and segregation of powders (Barajas 
et al., 2007). The versatility and rapidness of NIRS enables increased process 
understanding, better process control and improved quality of drug products (Räsänen 
and Sandler, 2007).  
2.10.2 Raman spectroscopy as real-time monitoring tool 
Raman spectroscopy has become established in pharmaceutical field.  There are 
numerous of applications for Raman and they extend from screening in early phase 
discovery to final product testing in manufacturing (Rantanen, 2007). Raman 
spectroscopy has been used for example to monitor crystallisation (Starbuck et al., 2002), 
polymorph screening (Campbell Roberts et al, 2002), hydrate forming (Wikström et al., 
2005) and dehydratation (Aaltonen et al., 2007; Kogermann et al., 2007ab; Kogermann et 
al., 2008), drying (Aaltonen et al., 2007), content uniformity measurements (Vergote et 
al., 2004), granulation (Wikström et al., 2005), homogenisation of suspensions (De Beer 
et al., 2006), mixing (Vergote et al., 2004; Hausman et al., 2005) and coating (Romero-
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Torres et al., 2006). In addition it has been successfully used as a quality control tool 
(Niemczyk et al., 1998) and it can differentiate the crystalline and amorphous samples 
(Langkilde et al., 1997; Taylor and Zografi, 1998; Savolainen et al., 2007). Nevertheless, 
the number of, especially real-time physical measurements have been limited in the 
literature. Few reports are available on the applicability of Raman spectroscopy for tablet 
hardness determination, (Wang et al., 2002; Picker-Freyer and Schmidt, 2004; Williams 
et al., 2004; Johansson et al., 2005) and particle size determination, (Wang et al., 2002; 
Williams et al., 2004; Hu et al., 2006) but these were not real-time measurements. 
However, Raman can also be utilised in real-time. Raman spectroscopy is a suitable PAT 
tool to control the pharmaceutical unit processes. Raman spectroscopy not only allows 
real-time measurements, but it also helps to understand the process.  
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3. Aims of the study 
The overall aim of this thesis was to study pharmaceutical powder technology processes 
at real-time in order to gain deeper understanding from the process. 
 
The specific aims of this study were: 
 
1. to study whether NIRS is suitable for measuring the degree of mixing in poorly 
miscible powder mixtures (I) 
 
2. to create a coloured heat indicator and to present a new practical way to visualise 
the progress of the heat in the mass during fluidisation (IV) 
 
3. to evaluate the particle size of granules during the tabletting process in order to 
examine segregation phenomenon during compression (III) 
 
4. to evaluate how different granule size distributions affect the tablet compression 
process. The emphasis was to develop new analysis methods for compression data 
for entire batches. (V) 
 
5. to find out is there a correlation between tablet weights and compression force 
(III) 
 
6. to determine the applicability of Raman spectroscopy for rapid crushing strength 
determination of intact tablets (II) 
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4. Materials and methods 
4.1 Materials 
Carbamazepine (CBZ, Hawkins, inc. Pharmaceutical group, Minneapolis, USA (I)) and 
theophylline anhydrate (TP, BASF Corporation, Bishop, USA (III, V); BASF 
Corporation, Ludwigshafen, Germany (V)) and were used as model drugs. The 
commercial ChromaZone® (CZ, ChromaZone, Flintshire, Great Britain (IV)) powders 
were used as heat indicators and microcrystalline spheres (cellets, neutral pellets of 
Syntapharm GmbH, Mülheim an der Ruhr, Germany (III, V)) were used as a model 
granules. Polyvinylpyrrolidone (PVP, Kollidon K25 (II), Kollidon K30 (III, IV, V) 
BASF, Ludwigshafen, Germany), α-lactose monohydrate (LMH, DMV International 
GmbH, Veghel, The Netherlands (I, III, IV, V)), hydroxypropyl methylcellulose 
(HPMC, Methocel E5, The Dow Chemical Company, Midland, USA (IV)) and 
magnesium stearate (MS, Orion Pharma, Espoo, Finland (II-V)) were used as excipients.  
4.2 Methods 
4.2.1 Characterisation of materials 
In study I CBZ was identified as a polymorph III by NIRS and X-ray powder diffraction 
(XRPD). CBZ was micronised and its particle size was around 300 nm measured with 
Zetasizer 3000 HAS (Malvern Instruments, Worcestershire, UK) based on intensity 
measurement. The particle shape seemed spherical. The particle size and shape appear in 
the SEM images (Fig. 7). In addition to the 300 nm particles, the powder also contained 
larger particles. The small particles aggregate in the CBZ powder. The particle size of 
used LMH was, according to the manufacturer, 200 M (i.e. 75 µm). According to the 
SEM image the LMH powder also contained smaller particles. The CBZ particles were 
about 250 times smaller than LMH particles.  
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Figure 7. SEM micrographs of CBZ (a1, a2) and LHM (b1, b2).  
 
CZ is a microencapsulated thermochromic pigment which changes from coloured to 
colourless as the temperature rises. With decreasing temperature the colour returns.  
CZ pigments were used in study IV. The microcapsules are individual droplets of 
chromogenic material with an impervious polymeric wall. The particle size of the CZ 
powders was 6 µm. The microcapsule wall can withstand most standard mixing and 
application procedures (ChromaZone, 2010). In this study, powders which activation 
temperatures were 31 (green; CZ31), 35 (pink; CZ35) and 40°C (blue; CZ40) were used.  
 
Pellets prepared from MCC in the other words cellets with a particle size fraction of 200 
µm (cel200) and 700 µm (cel700) were used as model (III and V). SEM micrographs of 
cel200 and cel700 are presented in Figure 8. In addition cellets with particle size 1000 
µm were used in study IV. 
 
 
Figure 8. SEM micrographs of cellets. A. cel200, B. cel700. 
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The model drug in the studies II, III and V was TP. It initial particle size was 100 M and 
200 M in the study II and 200 M in the studies III and V. SEM micrographs of TP are 
presented in Figure 9. 
 
 
Figure 9. SEM micrographs of TP. A. 100M, B. 200M. 
4.2.2 Mixing (I-V) 
The batch size was 25.0 g and the filling rate was approximately 80% (v/v) in the CBZ 
mixing study (I). The dominant substance was first weighed directly in the jar, followed 
by the residual substance. The CBZ percentages for the calibration model were 0, 1, 5, 
10, 15, 20, 25, 30, 40, 45, 50, 60, 70, 75, 80, 85, 90 and 100%. The powders for the 
calibration model were mixed in a Turbula mixer (Willy A. Bachofen AG 
Maschinenfabrik, Basel, Switzerland) until the mixtures were mixed homogenously 
according to the UV-Vis analysis. The experimental batches were mixed at varying 
speeds and concentrations, and the experiment included nine replicates according to the 
experiment chart. The mixing time was 14 min for all of the experimental batches. The 
experiment chart was created with MODDE software (Umetrics, Umeå, Sweden). All of 
the powders were stored in 45% RH to reduce the electrostatic charges at least 72 h 
before the mixing.  
 
Binary mixture of cel200 (50% w/w) and cel700 (50% w/w) was mixed using a Turbula 
blender at mixing speed of 46 rpm and mixing time of 3 min (III and V). The batch size 
was 800 g and a 2.0 l mixing jar was used. After mixing, the lubricant (0.5%, w/w) was 
added to the middle of the mass and mixed for an additional 3 min.  
 
The granules were mixed with MS in a Turbula blender at a mixing speed of 46 rpm and 
mixing time of 3 min (II-V). The batch size was 250 g (III, V) and the materials were 
loaded into a glass jar in a systemic fashion, with MS in the middle of the jar (49.5% 
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granules – 1% MS – 49.5% granules) (II, III, V). The concentration of MS was  
1% (w/w) (III, V), 0.5% (w/w) (II) or 0.1% (IV).  
4.2.3 Granulation (II -V) 
The TP and LMH were granulated with a 7.5% aqueous solution of PVP in  
an automated bench-scale fluid bed granulator (Glatt WSG5, Glatt Process technology 
GmbH, Binzen, Germany) (II, III, V). The instrumentation system is described by 
Rantanen and coworkers (2000c). The batch size for granulation was 4.0 kg and the 
amount of both solid materials was 2.0 kg. In addition, the amount of the PVP solution 
was 2.0 kg (III, V).  
 
In study III two granulation batches were produced: G1 and G2. SEM micrographs from 
G1 and G2 are presented in Figure 10. The RH of the inlet air was 55% during the  
G1 granulation and 49% for G2 granulation. In addition, the flow rate of the granulation 
liquid was 84 g/min and 70 g/min, respectively. Other parameters such as atomisation 
pressure and nozzle height were held constant.   
 
 
Figure 10. SEM micrographs from TP granules. A. Batch G1 and B. Batch G2.  
 
In study V 18 batches of granules including three centre point triplicates were granulated. 
SEM micrographs of the granules from five chosen batches are presented in Figure 11. 
The design of experiments and the variables for granulation process have been specified 
by Närvänen and coworkers (2008). According to the model by Närvänen and coworkers 
the granulation liquid feed rate was altered in function of RH of inlet air. The inlet air 
temperature was fixed to 40ºC for the granulation and 60ºC for the drying phase. Other 
parameters such as atomisation pressure and nozzle height were held constant.   
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Figure 11. SEM micrographs of TP granules manufactured in the study V. A. Batch 2, B. Batch 5,  
C. Batch 9, D. Batch 13, E. Batch 17, F. Close-up image from batch 13. Magnification is 50x for A to E 
and 500x for F.  
 
After granulation the granules were poured through a 3.15 mm sieve to remove any 
clumps (III, V). The granules were thereafter distributed, using a sample divider (Fritsch 
Sample Divider Laborette 27; Fritsch GmbH, Idar-Oberstein, Germany) for tabletting.  
 
CZ powders were manually granulated with LMH (IV). Granulation liquid was 20% 
polyvinylpyrrolidone-water liquid. Used CZ concentration was 5% (w/w). The moist 
mass was pushed through 1 mm sieve and the granules were dried 2 h in room 
temperature. After drying the granules were sieved first through 1.0 mm sieve and then 
the granules which penetrated the 1.0 mm sieve were sieved through 0.5 mm sieve. 
Resulting three particle size groups which were small (S) (< 0.5 mm), medium (M)  
(0.5 mm – 1.0 mm) and large (L) (> 1.0 mm). In addition fourth group was also 
granulated. It contained 15% (w/w) of CZ31 powder and it was used to study how the 
indicator content affected colour values.  
4.2.4 Coating (IV) 
Cel1000 were coated with CZ powders using Caleva top-spray coating equipment 
(Caleva Mini Coater, Caleva Process Solutions, Dorset, Great Britain) (IV). The coating 
liquid contained 1% (w/w) CZ powder, and 5% (w/w) HPMC. The batch size was 40 g 
and the average consumption of coating liquid was about 25 ml per coating process. The 
pellets were fluidised with mechanical vibration and air flow during the coating process. 
The frequency of the vibration was 17 Hz and amplitude 5 mm. The air flow rate was  
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4 m/s and the temperature of air was 50ºC. Spray pressure was 0.5 bar and the nozzle 
height was 140 mm. The flow rate of the coating liquid was 35 ml/h. The pellets were 
coated first for 15 min and then they were dried in the air flow for 10 min without the 
liquid feed. This procedure was repeated three times.  
4.2.5 Fluidisation (IV) 
The granules and the coated pellets were fluidised to observe the progress of the heat 
flow in the material and to study the heat indicator properties of the CZ materials (IV). 
The used equipment was a multichamber microscale fluid bed device (MMFD), (Ariacon 
Oy, Turku, Finland). The apparatus involves four individual glass chambers which inlet 
air rate and temperature can be controlled individually in each chamber. Though, in this 
study only one chamber was used. The equipment is attached to a process air control unit 
(Ilmasäätö Oy, Turku, Finland). The control unit is used to control the humidity and the 
temperature of the inlet air. The set-up for colour monitoring is presented in Figure 12.  
 
 
Figure 12. Set-up for colour monitoring during fluidisation. A. Multichamber microscale fluid bed device 
and its control unit. B. Fluid bed chamber and the colorimeter. 
 
All of the samples were fluidised with three temperatures and with three inlet air speeds. 
If the particles were fluidised with even higher air flow rates than the highest used air 
flow rate the movement of granules was so intensive that the colorimeter “saw” through 
the fluidised material. In this case the colorimeter did not measure the granules in the 
chamber but background behind the chamber. When measuring powders, the L*a*b* 
values can vary depending on the density of the powder and the surface conditions. To 
avoid errors, usually a fixed amount of powder is placed into a container of a fixed shape 
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and size and maintaining the surface quality. In fluid bed dryer the mass was moving 
continuously. The temperature was chosen according to the activation temperatures of the 
CZ-materials. The temperature was increased until the L*a*b* value was not changing 
notably. This ensured that the temperature was steady in the entire mass, not just near the 
sensor. The colour values were measured before the fluidisation, various times during the 
fluidisation and after the fluidisation during the cooling period with some samples. The 
batch size during the fluidisations was 5 g. In study IV the fluid bed drying was  
an expedient for study the changes in the colour of the indicators not the target of 
investigation as such.  
4.2.6 Tabletting (II, III, V) 
After lubricant mixing the granules were tabletted using an instrumented eccentric 
tabletting machine (Korsch EK-0, Erweka Apparatebau, Heusenstamm, Germany) (II, III 
and V). The machine was equipped with strain gauges and a feed shoe. Flat-faced 9 mm 
punches were used in all of the tabletting studies (II, III, V). The rotating speed was  
30, 61 and 60 rpm, in the studies II, III and V, respectively. 
 
The tablets were compressed so that their crushing strengths were between 30 N and  
200 N and the tablet weight was adjusted to 250 mg (II). There were five groups of 
crushing strengths. Each tablet was treated individually so that the response (crushing 
strength) could be linked to the corresponding spectra measured from the same tablet.  
 
In study V the weight of the tablets was adjusted to 250 mg and the crushing strength to 
60 N. In study III the crushing strength of the tablets was set to 65 N. During tablet 
compression Fup, Flp and Fe were recorded (III, V).  
 
Feff was also calculated as an additional tabletting parameter (Eq. 2)  
 
lpupeff FFF ⋅= .       (Eq. 2) 
 
The Feff is used because it explains the compression behaviour more accurate than for 
instance the average of the upper and lower punch force (Yliruusi and Antikainen, 1997). 
Feff assumably minimises the effects of the inhomogeneous structure of compressed 
tablets such as die wall friction, particle rearrangement, partial melting, recrystallisation 
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and different types of deformation (Marshal, 1986; Yliruusi and Antikainen, 1997).  
The SD of the relative error (srel) was also calculated (III). 
 
In the studies III and V the cellet mixture was tabletted, using the same instrumented 
eccentric tabletting machine (Korsch EK-0). The tablet mass was set to 530 mg.  
No tablets were formed, when Fup was over 13 500 N. Even though no tablets were 
formed, the compression force data of the Fup and Flp and Fe were recorded for further 
investigation.  
 
In the study III the granule samples from the die, corresponding to the tablets, were also 
collected for particle size determination. The sampling points for particle size 
measurements were determined according to the Fup behaviour. The sampling method is 
described more closely in publication III.  
 
Various methods were used to analyze tabletting data in order to define both short and 
long-time-scale undulation in the study V. All of the analyses were performed using 
Matlab software (v 7.0, The MathWorks Inc., Natick, USA). The description of the 
analysis methods can be found in publication V.  
4.2.7 Tablet properties (II, III, V) 
In study III approximately with 100 tablets intervals, 10 tablets were collected during 
tabletting. Tablets were collected manually in order to link each individual tablet with the 
corresponding punch force.  
 
Before analysis the tablets were collected in the plastic tubes in the same order in which 
they were compressed in study V. This procedure ensured that each tablet was analysed 
individually. Hence, the results were not averaged as prevailing method normally does.  
A novel feeding apparatus was used for weighing of the tablets. The machine dropped 
tablets from the plastic tube one at the time and dropping time interval was kept the same. 
The tablets were dropped in the Multitester apparatus (Erweka GmbH, Heusenstamm, 
Germany). Multitester measured the weight, diameters and crushing strength of the tablet. 
Only weights of the tablets were further analysed in study V. Finally, the crushing 
strengths were measured with an indirect Multicheck diametral hardness apparatus in 
study II.  
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4.2.8 Moisture content (III, IV) 
The moisture content of the granules was measured using moisture analyser (Sartorius, 
MA100, Göttingen, Germany) (III and IV). A continuous heating was used until 105ºC 
and the measurement ended when the weight loss was decreased to 1 mg/24 sec. The 
samples were measured after granulation, after being in the desiccator (0% RH) for 24 h 
and after fluidisation (IV).  In addition, the water activity (aw) of the granules was 
determined, using a dew point hygrometer (Aqualab Series 3 TE; ADAB Analytical 
Devices Ab, Stockholm, Sweden) (III).  
 
The moisture equalises electric charges on the particle surfaces (Antikainen, 2003) and 
therefore increases the flowability (Zhuikova et al., 2009). In addition water can act as 
lubricant during tabletting and even be a part of bonding (hydrogen bonding and liquid 
bridges) during compression (Antikainen, 2003). On that account the moisture content of 
material to be compressed has to be standardised. Thus, the cellet mixture was stored at 
50% RH and ambient temperature for 1 month (III and V).  
4.2.9 Particle size (III, V) 
The particle size was measured using Parsum® equipment (IPP 70; Gesellschaft für 
Partikel-, Strömungs- und Umweltsmesstechnik mbH, Chemnitz, Germany) (III, V).  
The Parsum® method is accurate even with small sample size (Närvänen et al., 2008). 
The SFT determines the chord length of each particle passing through the laser light 
beam (Petrak, 2002; Närvänen et al., 2008). The apparatus was installed on a laboratory 
table and the sample was poured through the orifice (diameter 4 mm), using a funnel. The 
particles were dispersed by pressurised air. The particle size (chord length) distribution 
was converted to volume particle size distribution. 
 
The particle size was also measured using sieves as a comparison for Parsum method (V). 
For sieve analysis, a 50 g sample was vibrated using an automatic sieve shaker (Fritsch 
analysette, Idar-Oberstein, Germany) for 5 min. The sieve analysis (range 71–2000 µm 
with √2 increment) was performed in triplicate and the mean value for the median 
granule size was determined.  
4.2.10 Surface properties (I, II, III, V) 
Visual images of the particles corresponding to the tablets were measured, using  
a prototype 3D surface roughness instrument (iPharmaceutics Ltd., Helsinki, Finland) 
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(III). Its operational principle is described by Laitinen and coworkers (2004).  
The roughness parameter was calculated for each 3D image using equation adapted from 
publication by Krogars and coworkers (2002).  
 
Scanning electron microscopy (I, II, III, V) 
SEM images were measured with Zeiss DSM 962 scanning electron microscope 
(Oberkochen, Germany) and they were used to visually characterise the powder mixtures 
(I), the surface of the tablets (II) and the morphology of the cellets and granules (III, V). 
 
Non-contact laser profilometry (II) 
The surface profile of the tablets, i.e. roughness, was determined with non-contact LP 
(UBM Microfocus Optical Measuring system, UBM Messtechnik GmbH, Ettlingen, 
Germany), using three 100 M TP tablets from each crushing strength group (II). The 
image size was 2 mm x 2 mm and the measuring range was ± 50 µm. The laser spot size 
was 1 µm and the resolution 200 points per mm. The laser input was 0.2 mW and the 
wavelength 780 nm. After data collection, the image was levelled to remove slope caused 
by tilting of the tablet surface, using Ubsoft software (v 2.8 DOS, UBM Messtechnik 
GmbH, Ettlingen, Germany). The roughness parameters were calculated from these 
corrected images. The most important of these were average roughness (Ra) and root-
mean-square roughness (Rq). These parameters were standardised and are presented in 
full detail in British Standard (1972) and in the UBM System Reference Guide (1995). 
The parameters described the tablet surface, using comparable numerical values which 
gave better results than other methods. The surface characteristics of the tablets were 
examined with contriving micrographs using Mathematica software (v 5.1, Wolfram 
Research Inc., Champaign, USA). 
4.2.11 Analytical methods 
UV-Vis assay for CBZ (I) 
The calibration curve for the UV-Vis assay was prepared for the CBZ solutions in the 
study I. In the 100% CBZ sample there was 60.0 mg of CBZ which was dissolved with 
25.0 ml of ethanol (96%). An assay for CBZ powder mixtures was made for the 
calibration set batches in concentrations of 1, 10, 30, 60, 70 and 100%. CBZ 
concentrations were determined with a UV/Vis spectrophotometer (Ultrospec II, LKB 
Biochrom Ltd., Cambridge, UK) at 285 nm.  
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Colour measurement (IV) 
Konica-Minolta CR-400 tristimulus colorimeter with 8 mm aperture was used to measure 
the L*a*b* values in study IV. The colorimeter was attached in contact with fluidisation 
chamber. The measurement was controlled with the Väritohtori (Mitaten Oy, Kauniainen, 
Finland) software.  
Near infrared spectroscopy (I) 
NIRS was used to measure the concentration of CBZ mixtures in study I. The NIRS setup 
consisted of a NIRS spectrometer with an InGaAs diode array detector, tungsten light 
source, and six 400-µm collecting optical fibres around one collection fibre (Control 
Development, Inc., South Bend, IN). The white teflon served as a reference  
(99% reflective Spectralon, Labsphere Inc., North Sutton, USA). Spec32 software (v 4.0, 
Control Development, Inc., South Bend, USA) was used to control the NIR spectrometer. 
The batches were measured at the spectral region from 1100 to 2200 nm in the same jars 
they were mixed using the fibre-optic probe. Consequently, removal of the sample was 
unnecessary. Measurements were performed at three different depths in the batch: at the 
surface, in the middle and at the bottom. The data were filtered during the measurement. 
The procedure is described more closely in publication I.  
Raman spectroscopy (II) 
Raman spectroscopy was used to measure the crushing strength of tablets in study II. The 
Raman spectra were collected using a Raman spectrometer (Control Development Inc., 
South Bend, USA) equipped with a thermoelectrically cooled CCD detector and a fibre-
optic probe (RamanProbe, InPhotonics, Norwood, USA). A 500 mW laser source  
at 785 nm was used (Starbright 785S, Torsana Laser Technologies, Skodsborg, 
Denmark). The spectral range recorded was between 100 and 2200 cm−1 with a 2 s 
integration time and by averaging three scans. At least 20 parallel tablets from each 
crushing strength group were measured using Raman spectroscopy from the lower side of 
the tablets. During Raman measurement the tablet was rotated and the distance between 
the tablet surface and the probe was fixed to 8 mm.  
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4.2.12 Data analysis 
Principal component analysis (I, V) 
The PCA plot provided a graphical presentation of the spectra in the calibration set in 
study I. Granule size distributions of the batches were analysed using PCA in the study 
V. PCA categorised data so that the similar distributions are plotted at the same area in 
the scatter plot. Analysis was performed using SIMCA-P (v 10.5, Umetrics, Umeå, 
Sweden) software. 
Partial least squares regression (I, II) 
The PLS regression was used to define the degree of mixing in study I. The PLS 
modelling was performed with SIMCA-P software. Before modelling, the data were SNV 
corrected and mean centered. Such matrix normalisation is usually recommended to 
improve the predictability and interpretation of the PLS regression model (Eriksson et al., 
2001). The batches of the calibration model were used to create a PLS model. The actual 
measurements were fitted to this calibration model with SIMCA-P software.  
 
A PLS model was also used in study II to define the correlation between the spectra and 
the crushing strength of the tablets. The spectral region between 400 and 1730 cm−1 was 
used in the data analysis. PLS modelling was performed with SIMCA-P software. Every 
third spectrum was used to create the PLS model and the rest two thirds served as the test 
set. Hence, the spectra were collected and the model was tested equally for each crushing 
strength group. The parameters used to test the model performance were R2 and Q2.  
The spectra gained were standardised using UV correction before PLS modelling. 
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5. Results and discussion 
5.1 Mixing of poorly-miscible powders (I) 
Firstly, a calibration set samples were prepared and then measured and analysed. The 
mixing degree was measured from three different locations: a) on the surface, b) in the 
middle and c) at the bottom. Obtained results were used to create contour plots which 
expressed the degree of mixing in the experimental domain (Fig. 13). The determination 
of mixing degree is described in publication I.  Differences in the degree of mixing were 
large. Most of the batches were mixed well or moderately well, but some of the batches 
hardly mixed at all. This was desirable because one purpose of this study was to measure 
differences in mixing degrees of the batches to enable analysis of the degree of mixing.  
 
Figure 13. On the left hand side PCA score scatter 3D plot. The PCA plot provides a graphical presentation 
of the spectra in the calibration set. The arrows point towards increasing CBZ concentration. On the right 
hand side the concentration difference in the different layers described with the help of mixing degree 
values. The mixing degree value increases when the concentration difference (heterogeneity of the batch) 
increases. The darker colour indicates a higher degree of mixing.  
 
CBZ was difficult to mix because of its electrostatic nature and small particle size. 
Moreover, the size difference between CBZ and LMH presented a problem in mixing and 
in the NIR measurement. Increasing the RH of the air decreased, but did not eliminate, 
the problem. CBZ particles adsorbed to the surface of LMH particles which affected to 
the mixing behaviour of the mixtures (Bell et al., 1971, Malcolmson and Embleton, 
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1998). Mixing of cohesive powders can inflict significant problems in pharmaceutical 
powder processing. If the mixing parameters and environmental circumstances are not 
carefully selected the mixing can be ineffective even if the mixing time is substantially 
increased.  
5.2 Fluidisation of heat indicator materials (II) 
5.2.1 Colour change of heat indicator granules  
At first, the colour change of the granules was studied as visual demonstration.  
The granules were heated on the hot plate and they were cooled down afterwards  
(Fig. 14). The colour started to return from the edges where the temperature decreased at 
first. The CZ40 changed the colour most reliable, at first from blue to white and when 
cooling down from white to blue. Also CZ31 worked quite well. The colour change for 
CZ35 was not as clearly detectable.  
 
After visual characterisation granules and pellets were fluidised. The CZ40 group worked 
the best during the fluidisation. All the particle size groups changed their colour at  
40-41ºC. The colour of the CZ31 and the CZ40 groups was recovered very fast after the 
fluidisation and their colour after the fluidisation was as bright as before fluidisation. 
However, the colour of the granules from CZ35 group did not recover totally and the 
return was slower. It was also noticed that the colour values altered depending the 
particle size of the granules: smaller particles were lighter than the larger ones.  
5.2.2 Fluidisation behaviour 
The CZ granules and pellets were fluidised in the MMFD. Following observations were 
made during fluidisation process. 
 
The temperature in the chamber was lower than in the spot where the temperature sensor 
was located. The temperature difference was larger immediately after the elevation of the 
temperature but the difference was balanced when the temperature was kept constant for 
a while. The temperature decreased when going up in the chamber. The change rate of 
the temperature had an effect on colour change of the indicators. If the temperature of the 
air was increased too fast the temperature in the chamber did not have time to change to 
the value that the sensor was showing.  
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Figure 14. The colour change of the granules (from the right 31L, 35L, 40L) at the hot plate. Temperature 
was A. 25°C, B. 30°C, C. 35°C, D. 40°C, E. 45°C, F. 50°C measured from the bottom plate. 
 
 
The air flow rate affected the rate of colour change. The higher the speed, the faster the 
colour change. When air could flow through the mass it transferred the heat to the whole 
mass. In addition, the thickness of the fluidised bed had an effect on the heat behaviour of 
the mass. The thicker bed hindered the air flow more efficient than the thinner bed and 
that is why the heat was also transferred slower to the upper parts of the bed.  
 
Usually the edges of the chamber were cooler than the centre part. Therefore the colour in 
the centre parts became lighter faster. The temperature changed at first in the lower parts 
of the chamber and after that it raised upwards.  
 
Figure 15. Fluidisation of CZ samples. A. Only the surface of the pellet35 mass is fluidised (temperature 
33°C C and the air flow 270 ml/s). B. Pellet31 is slugging (31°C, 320 ml/s). C. Pellet40 is stuck at the 
bottom of the straight part of the chamber (38°C, 300 ml/s). D-F. The formation of the caverns of D. 31L 
(33°C, 240 ml/s), E. 40L (39°C, 180 ml/s) the mass warmed up first at the centre parts. F. 31 pellets  
(33°C, 325 ml/s). 
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The air flow in the chamber was different depending on the fluidised material and 
fluidisation parameters (Fig. 15.). Different fluidisation manners could be perceived. 
When the air flow was increased so that the mass started to move, a “crater flow” was 
developed especially with the smaller granules. In the crater flow the centre and lower 
particles were gushed through the centre to the surface. A problem occurred when 
measuring this kind of crater flow: the colorimeter measured only particles next to the 
chamber walls. The particles next to the chamber walls were usually cooler (and darker) 
than particles in the centre especially when the fluidisation was not sufficient. Different 
fluidisation manners of materials can inflict errors in measurements if they are not 
recognised when choosing fluidisation parameters.  
 
The fluidisation properties of the granules with different indicator but same particle size 
were very similar with each other. The large granules fluidised better than small. The 
fluidisation could be adjusted easily with air flow rate. The heat behaviour of the granules 
was better with medium size granules than with small and large granules.  
 
The pellets needed higher air flow rate than the granules mainly because they are denser. 
That is why they also kept the heat inside longer than granules and the colour return was 
slower.  The pellets were electrified if they were fluidised in high air flow and/or in the 
high temperature. The triboelectricity inflicts the sticking of the pellets into the chamber 
walls. A typical behaviour for the pellets was that they stuck on each other and did not 
move in the air flow. However, even if the air flow was not altered the pellets could 
suddenly start to flow again.  
5.2.3 Utilisation of heat indicators 
Although the equipments for measuring colours are available, the colour analysis is rarely 
employed in pharmaceutical industry (Šubert and Čižmárik, 2008). Hayauchi (2005) 
presented reliable and precise equipment for colour analysis. It was stated that visual 
colour matching without any colour measuring device is very inaccurate and there is wide 
variability even with the same person and especially between persons. That is why it 
would be important to measure colours with colorimeters. 
 
When using these kinds of colour indicators one must remember that their colour change 
is reversible contrary to physical changes in APIs which are irreversible. This can lead to 
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the fact that some extreme temperatures can be missed if the operator is not accurate and 
if the chamber is not totally transparent. 
 
The coloured heat indicators could be utilised for example with scaling up research when 
studying the changes at the heat flow in fluidisation chamber. When the scale of 
fluidisation chamber is increased also the amount of sensors should be increased. The 
placement of the sensors should be chosen so that they cover all temperature regions 
inside the chamber. The most important location is in the lower region where the 
incoming air is coming into the chamber. It is usually the hottest region where the 
temperature can change fast and possible physical changes can happen.  
 
In addition, heat sensitive colour indicators can be used for detecting conditions that 
would alter the crystal structure of active pharmaceutical ingredients or process induced 
transformation (PITs). Various APIs can possess multiple polymorphs or amorphous state 
when conditions (temperature and humidity) are changed. If these conditions are known, 
can indicators which change their colour at these specific conditions be used to visualise 
in which part of the chamber the changes are happening during fluidisation.  
 
The coloured heat indicators give an opportunity to visualise the process at real-time. The 
visual monitoring of colour is natural for humans and it can be very informative. In 
addition real-time quantitative colour analysis is possible with colorimeters. Finally at the 
best case even process understanding can be gained. 
5.3 Tabletting (II, III, V) 
5.3.1 The effect of particle size on tablettability (II, III, V) 
The effect of particle size to crushing strength of tablet was studied using two different 
sized TP particles, 200M and 100M, in the study II. The smaller particles endure higher 
crushing force than larger ones. This may be the result of increased interactions among 
the smaller particles during compression. Their surface area versus weight is higher than 
with the larger particles. TP is known to be a plastic material (Suihko et al., 2001), which 
supports this suggestion.  
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The batches could be divided according to their tablettability in the study V. 
Tablettability in this context is defined as general ability to form tablets with low 
variation in the compression data (or low weight variation of tablets). When these results 
were compared to the median particle size smaller particles gave usually better results in 
other words their tablettability was better. However there was a minimum particle size for 
adequate flowability. In order to find out the smallest acceptable particle size additional 
study was performed. The starting materials (TP, LMH, and PVP) were mixed with no 
granulation. This mixture faced difficulties upon tabletting because it did not flow from 
the hopper into the tabletting table. The mixture had the worst tabletting properties and 
there was a great fluctuation in Feff (Fig. 16). For these materials adequate d50 particle 
size for tabletting was found to be approximately 200 µm.  
 
Figure 16. The Feff forces of powder mixture, and five batches prepared in the study V. 
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In addition PCA was established based on particle size distributions measured with 
Parsum® equipment in study V. Similar size distributions were plotted to the same area in 
the scatter plot so the data can be divided according to the particle size distribution. The 
behaviour of the batches could not be explained only with the particle size, because 
above-mentioned groups were not consistent in the certain sector in the PCA scatter plot. 
This was due to the fact that also other things than particle size distribution affects the 
results.  
5.3.2 Effect of other factors on tablettability (III, V) 
The particle size and particle size distribution cannot alone explain the tablettability. 
Other factors influencing tablettability are flowability and surface texture of the granules. 
Also porosity, density, and particle shape could have an effect. In addition the better 
tablettability of smaller granules can be partly contributed by the behaviour of MS and 
humidity of air. Flowability of the smaller granules could be reduced by triboelectricity 
because the moisture in the larger granules equalises electric charges on the particle 
surfaces (Antikainen, 2006). The humidity decreased triboelectricity clearly deriving to 
substantially better flowability (Pingali et al., 2009). MS on the other hand lubricated the 
granule mass and the flowability increased.  
 
The shape and surface characteristics of the granules could have an influence on 
tablettability through flowability. Good flowability of the powder mixture assists to 
achieve favourable content uniformity and low weight variation of tablets (Fan et al., 
2005). It has been noticed that particle shape has an influence on filling of the tabletting 
die (Ridgway and Scotton, 1970) and packing density of particles (Pitkin and Carstensen, 
1990).  
 
Although the smaller particle seemed to pose the best properties for tabletting, the 
situation is not this clear in real life. When using the eccentric tabletting machine the 
mass is tabletted more easily than with rotational tabletting machines which have higher 
tabletting speed, larger masses, longer dwell time, and both punches are moving 
(Palmieri et al., 2005). In addition gained results cannot be generalised for other sized or 
shaped punches than flat-faced 9 mm. In general, the shape and size of the punch affect 
the filling of the die.  A larger die can be filled more efficiently when the particle size of 
compressed material stays unaltered. Particles pack differently near die walls than in the 
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middle of the mass. For instance oval shaped die has more wall surface and more “wall-
effect” than round-shaped die.  
 
In discussing particle size and its enlargement or decrease, one must consider the original 
particle size and other particle properties. For instance, it has been stated that particle size 
reduction improves flowability, but when the particle size was reduced under a certain 
limit the flowability became poorer (Marks and Sciarra, 1968). With decreasing particle 
size, interparticulate forces such as electrostatic and van der Waals forces can become 
more predominant (Harnby, 2000). In addition, tablet strength is not a simple function of 
particle size (Hersey et al., 1967). If particles form, via fragmenting or aggregation, the 
breakdown into smaller particles, can result in stronger tablets than the initial particle size 
predicts. The original particle size and size distribution should be always mentioned 
when presenting the results in which an alteration in the particle size will produce change 
in some phenomenon such as flowability. 
5.3.3 Segregation during tabletting (III, V) 
Segregation of powders can occur as a result of differences in the physical (i.e. particle 
size, surface area, particle shape) and mechanical (i.e. strength, elasticity, plasticity, 
brittleness) properties of the particles. It can eventually cause weight variation in tablets 
and therefore quality problems for the final dosage form. The effect of particle size on 
segregation during the tabletting process was studied using different sized cellets and 
granules with various properties.  
 
The segregation was studied by compressing cellets, which particle size was homogenous 
in the studies III and V. At first, cel200and cel700 were compressed using eccentric 
tabletting machine. The particle size distribution was very narrow for both the 200 µm 
and 700 µm cellets. The particle size of cellets had an effect on compression force during 
tabletting (Fig. 17). The force curve for cel200 was steady and there were not much 
differences between consecutive forces. The force curve for cel700 was steady for long-
time-scale examination but there was a substantially larger difference between 
consecutive forces compared to cel200 consecutive forces. This could be explained with 
the larger particle size of cel700. When the particles were larger the packing into the die 
varied more compared to smaller particles. If the size of the pellets was small enough, the 
mass filled the die evenly every time. A schematic diagram of the die filling for both 
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smaller and larger particle size cellets is presented in Figure 17. In theory, the same sized 
free flowing spherical particles are packed equally tight, no matter what the particle size. 
However, in reality larger gaps remain with the larger particles in the tabletting die 
because real granules are not freely flowing and the die walls disturb the packing. Even  
a single large particle can remarkably add the mass of a tablet. This phenomenon was 
also reported by Ridgway and Williams (1977) who concluded that the proportion of 
smaller particles had little effect on the bulk density of lactose granules. In addition, 
Laitinen and others (2004) stated that large particles did not fill the die completely, and 
varying amount of empty space was left between the granules. If the mass included 
several sized particles, like the pharmaceutical masses usually do, the smaller particles 
could fit to the gaps between the larger ones, leading to smaller undulation in the 
tabletting data. The increase in the particle size distribution could also increase the 
undulation compared to compression on only small particles. Variation in the mass in the 
die increased and the die was filled differently every time. In practice every mass induces 
some short-time-scale variation or difference between consecutive forces in the 
compression data. In addition, the mass with broad particle size distribution has a obvious 
possibility of segregation. In this study segregation was established with as simple way as 
possible. The binary mixture (50/50) of the aforementioned cellets was also tabletted. The 
segregation phenomena can be seen in the level of Fup as a large-time-scale undulation 
which is typical for segregation. Fluctuation of Fup during tabletting was found to be 
clearly smaller with cellets having a smaller particle size compared to that observed with 
cellets with a larger particle size. A broad particle size distribution induces segregation 
that influences tabletting force and tablet weight. When the particle size distribution is 
narrower there is no significant segregation and the level of Fup is kept more constant, as 
can be seen in the cellet tabletting.  
 
In study V the changes which are present in compression data were divided to two 
different kinds of phenomenon: short-time-scale variation (tablet-to-tablet changes) and 
large-time-scale undulation. Long-time-scale undulation is defined as “waving” kind of 
undulation which happens during the tabletting. Long-time-scale undulation can reveal 
for instance segregation or compaction of the mass in the hopper.  
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Figure 17. Effects of particle size of cellets on upper punch force during tabletting. Red line represents the 
tabletting behaviour of cel700 and black line represents the cel200. Blue line represents upper punch force 
during cellet mixture tabletting. Mixture contains cel200 and cel700 (50/50). (A) Schematic diagram of the 
die filling of smaller cellets, (B) larger cellets, and (C) cellet mixture. D. SEM micrograph of cel200 and E. 
cel700. 
5.3.4 Mathematical analysis of the compression data (V) 
Various methods were used to analyse tabletting data in study V. Short-time-scale 
variation was evaluated using amount of noise in the data. Long-time-scale undulation 
was studied describing linearity of the data, the quality of the fit for polynomial function 
into the data, and the relative quality of the fit. This mathematical processing is described 
more closely in publication V. In general if the data were smooth concerning with tablet-
to-tablet analysis no significant segregation occurred.  
 
According to the results in study V it seems that short-time-scale variation with small 
granules (d50 < 300 µm) is affected by flowability. d50 is the particle diameter at which 
50% of the particles have diameters that are greater or smaller than the d50 value. If the 
granules have poor flowability they do not have time to flow into the die, which will 
induce short-time-scale variation to the compression data. With larger granules short-
time-scale variation is due to uneven filling of the die. As mentioned before large 
granules fill the die in variable manner every time and establish different densities for the 
mass in the die. Large-time-scale undulation can be introduced if large granules have  
a broad size distribution. This is normally segregation. If the granule size distribution is 
narrow there is no large-time-scale undulation. 
 
According to the FDA draft guidance, product and process specifications are based on 
understanding of how formulation and process factors affect product performance  
(FDA, 2004). In addition there is the capability of process control and the quality of 
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products can be ensured at real-time. Before-mentioned mathematical methods for 
analysing the compression data could be used for real-time monitoring. This would 
enable detection of segregation during tabletting and required means could be used to 
prevent variations in the content uniformity of tablets. This prevents rejection of 
products, decreases waste and enables the real-time product release which are primary 
goals for utilisation of PAT. 
5.3.5 Correlation between upper punch force and tablet weights (III) 
A clear correlation between the level of Fup and tablet weights was detected in the study 
III (Fig. 18). According to the results the tablet weights were increased when the Fup was 
increased in both granule batches. This phenomenon was also described previously 
(Antikainen et al, 2006). 
 
Figure 18. Upper punch force during tabletting (gray lines) and mass variation (black points) in  
A. G1 tablets and B. G2 tablets. Cumulative particle size distribution of C. G1 granules and D. G2 granules 
during tabletting. Sampling points for particle size measurement are marked with circles. 
 
The granule size distributions change according to the compression force and tablet 
weight. The granule size was smaller when the force and tablet weight were larger and 
vice versa. Smaller particles can fill the die more efficiently than the larger particles, 
leading to a heavier tablet. The d50 values also support these observations.  
5.4 Mechanical strength of tablets (II) 
5.4.1 Dependence of surface texture on mechanical strength of tablets (II) 
SEM and LP methods were used as additional methods to visually illustrate the tablet 
surface profile in study II. The surface morphology and texture were related to the 
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crushing strength of the tablets. This was seen in the SEM and LP micrographs from the 
surfaces of the TP containing tablets (Fig. 19). 
 
 
 
Figure 19. On the left hand side the surface of TP tablets (200M) became smoother as the compression 
force was increased. SEM images on tablets with crushing strengths of (a) 35 N, (b) 110 N, (c) 150 N,  
(d) 185 N, and (e) 205 N. Scale bar 50 µm. On the right hand side the surface profiles of the TP tablets 
(100M) measured using non-contact laser profilometry. (a) 35 N, (b) 110 N, (c) 150 N, (d) 185 N, and  
(e) 205 N. 
 
 
 
Figure 20. Raman spectra of the TP tablets. The measured spectra (100–2200 cm−1) and magnification 
from one peak to show the baseline shifting. The intensity increase, which correlates with increase in the 
crushing strength, is marked with blue arrow.  
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 The LP method is in some cases more efficient because quantitative roughness 
parameters can also be calculated in contrast to SEM images. The SEM and LP 
micrographs representing the tablets indicate that clear differences exist within the 
surface textures of the tablets depending on their crushing strength (i.e. the compression 
force applied in tabletting). As expected, the higher the crushing strengths of the tablets, 
the smoother were the surfaces of the tablets. Clear differences in the surface roughness 
properties of the tablets were observed in tablets compressed using lower compression 
forces. However, since the crushing strength of the tablets was 100 N or more, the 
differences in surface roughness properties within the tablets were no longer evident. 
Application of higher compression forces in tabletting results in greater tendency for 
deformation and/or fragmentation of the individual powder particles and granules, thus 
making it more challenging to detect differences in the surface texture of the tablets.  
In most cases the smoother surface indicates larger crushing strength of the tablet. 
However, it cannot be generalized to all situations. For instance if the surface of the 
compressed material melts or if capping, sticking or picking happens during tabletting the 
surface roughness does not implicate the crushing strength.  
5.4.2 Crushing strength of tablets measured using Raman spectroscopy (II) 
Raman spectroscopy was used as an alternative vibrational spectroscopy technique to 
determine the mechanical strength of the TP tablets in study II. Raman spectroscopy 
detected increases in crushing strength mainly as a smoothing of the tablet surface. When 
the compression force was high, the surface of the tablet was smoother and there were 
fewer pores in the tablet. When the compression force was increased, the structure of the 
material condensed as the interfaces between air and the material decreased. In this case, 
the Raman radiation penetrated the material more easily because the interfaces were 
diminished, which decreased scattering from the surface.  
 
No specific peaks in the spectra were sensitive enough to detect changes in the crushing 
strength values of the tablets, due to baseline shifting which occurred evenly throughout 
the spectra (Fig. 20). Since the crushing strength is a physical property, one must be 
careful that preprocessing of the spectra will not destroy the information. Typical 
preprocessing methods such as mean centering and corrections such as SNV, MSC, and 
the derivates cannot be used because they lose the baseline-shifting information. The data 
can be modelled as such or after basic scaling.  
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The correlation between the crushing strengths measured with the Multicheck apparatus 
and with Raman spectrometry was studied, using multivariate modelling. The PLS model 
was established, using four principal components (PC) for both TP grades after  
UV scaling. All four components explained 82.7% of the X-variance for the 100 M grade 
and 98.8% of the X-variance for the 200 M grade. The Q2 value was higher than 0.8 and 
R2 value higher than 0.9. In addition, the loadings for the first principal component (PC 
1) substantially resembled the Raman spectra.  
 
There was a correlation between the measured and predicted crushing strength values 
(Raman spectra) for TP tablets. The SDs of the measured and predicted crushing strength 
values were determined. The Raman spectra were obtained for both TP grades and were 
very similar. The results indicated that the correlation between the crushing strength data 
for the TP tablets and the Raman spectra applied was excellent.  
 
To determine whether the Raman technique detects the crushing strength of the  
TP tablets as smoothness of the surface or whether it detects the structure and bonding in 
the tablet, in addition Raman spectra were measured from the plane of fracture of the 
tablets. The tablets were halved and the spectra measured from the plane of fracture, 
using a rotating sample. No correlation was found with either of the TP tablet grades. In 
conclusion Raman spectroscopy detected the crushing strength of the TP tablets as  
a smoothing of the tablet. In addition it can be concluded that if there is picking, sticking 
or capping happening during tabletting, the Raman method does not reveal the accurate 
crushing strength values.  
 
Raman spectroscopy, among other vibrational spectroscopy techniques, is applicable as  
a rapid and noninvasive method for predicting the crushing strength of tablets. However, 
the results indicate strongly that determination of the crushing strength of tablet using 
Raman spectroscopy, demands a well-established and accurate method.  
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5.5 Sources of error using spectroscopic methods (I, II) 
NIRS was used to study the mixing process of CBZ and LMH in study I. The coating of 
the LMH particles with the CBZ particles caused changes in the NIR signal when the 
mixing proceeded (Fig. 21). The small CBZ particles formed clusters between bigger 
LMH particles in the early phase of the mixing. The CBZ particles covered the LMH 
particles when the mixing proceeded. The NIRS detected the situation differently in these 
two circumstances. In the early stage of the mixing, NIR radiation reflected from one 
CBZ particle to another CBZ particle before it reflected back to the detector. In that case, 
NIRS detected more CBZ than the calibration mixture contained. When CBZ covered 
LMH, NIR radiation reflected straight form the LMH particles. The calibration had to be 
performed with completely homogeneous mixtures which why long mixing times were 
used. When the powders were mixed for a long time, the charging of the CBZ particles 
and the coating increased. The increase in homogeneity could also be seen as a decrease 
in the SD of the predicted CBZ concentrations with different concentration levels.  
 
 
 
Figure 21. Behaviour of the NIR signal in the mixture. (A) The small CBZ particles form clusters between 
larger LMH particles in the early phase of the mixing. NIR light reflects from CBZ particle to CBZ particle 
before it reflects back to the detector in the early stage of the mixing. (B) The CBZ particles cover the 
LMH particles as the mixing proceeds. NIR radiation reflects from the LMH particles. 
 
The densification of the batches can be a source of error because the geometry of 
measurement changes. In study I the intensity of the NIRS measurement increased with 
the predicted CBZ concentration when the powder was very tight. The distance of the 
batch from the probe was also crucial for the geometry of the measurement (Fig. 22).  
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The geometry of the measurement changed together with the distance from receiver.  
The intensity also changed if the distance between the batch and the probe was too high.  
 
 
Figure 22. The influence of geometry on the NIRS measurement. Only very little reflection can reach the 
receiver if the sample is at distance A from the receiver. If the sample is moved further away from the 
receiver, to distance B the batch reflects more radiation that can reach the receiver and the intensity 
increases. The intensity also changed if the distance between the sample and the probe is too high. 
 
In NIRS reflectance measurement, the bulk density (i.e. geometry changes in the NIR 
measurement) of the mass affects among other things the intensity of the reflected signal. 
Because of this phenomenon, the level of the measured absorption spectrum fluctuates 
during measurement. This variation in the intensity of the spectra results from to the fact 
that the probe can densify the sample being in contact with the powder. The density of 
some batches is also higher at the edges of the batch jar due to centrifugal forces during 
the mixing process. A complete computational correction of the fluctuation phenomenon 
is impossible today.  
 
The sources of variation in spectroscopy measurements lie at 1) the material used,  
2) the measuring geometry (set-up), and 3) the distance between the probe and the 
sample. Analysis of the tablet with spectroscopic methods requires considerable 
experience. Due to spatial variations and inhomogeneities of the tablet spectroscopic 
assessment is a precise task that can give differing results, depending on how the 
measurement is performed. The wavelength and compression force can also affect the 
intensity of the signal. The importance of these factors is even more pronounced when 
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measuring physical properties. For instance the results indicate strongly that 
determination of the crushing strength of tablets, using Raman spectroscopy, demands  
a very accurate method. Hence, every formulation demands its own model and 
production parameters have to be constant.  
 
When using NIRS at least some of the samples must be analysed with a reference 
technique such as high performance liquid chromatography (HPLC) or UV-Vis 
spectrophotometry. The real concentrations can be determined with methods that can be 
used in a calibration model or validation process (Berntsson et al., 2000).  
 
Raman spectroscopic measurement is critical, because the area measured is very small 
(scale of scrutiny), which explains that the sample must be moved, usually rotated. When 
the sample is rotated the measurement covers a larger area and warming of the sample 
can also be reduced.  A rotating sample holder was used to achieve high repeatability 
(Szostak and Mazurek, 2002). When physical properties are measured the distance 
between the sample and the probe must be standardised (Lombardi et al., 1994). The 
change in distance causes the same alterations in the spectra as does the increase in the 
crushing strength of the tablet.  
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6. Summary and conclusions  
There is a need for better understanding of the processes and new ideas to develop 
traditional manufacturing procedures. PAT has been developed to improve understanding 
of the pharmaceutical processes and establish methods to monitor and control processes. 
The real-time process monitoring demands tools, which enable fast and noninvasive 
measurements with sufficient accuracy. In this study three pharmaceutical processes were 
investigated: drying, mixing and tabletting. In addition tablet properties were evaluated. 
Real-time monitoring was performed with NIR and Raman spectroscopies, colour 
analysis, particle size analysis and compression data during tabletting was evaluated 
using mathematical modelling.  
 
NIRS was used to analyse mixing of poorly-miscible powders. NIRS detected differences 
in the mixing degrees. However, the difference in particle size of the materials and the 
densification due to the electrostatic nature of CBZ caused problems in the  
NIR measurement.  
 
Raman spectroscopy was employed to measure strength of the tablets. A correlation 
between measured and predicted crushing strength values for the tablets was achieved. 
With Raman spectroscopy, shifting of the baseline was observed as the crushing strengths 
of the tablets (and the smoothness of the tablet surface) were increased. Consequently, 
correlation between the crushing strength data on the tablets and Raman spectra was 
observed. Raman spectroscopy is a promising alternative for established real-time tablet-
testing methods for some tablet formulations. Spectroscopic methods require accurate 
operation and method development. 
 
Colour indicators for heat detection were developed to mimic the heat sensitive API in 
the pharmaceutical drying process. Indicators detected the progression of heat in the 
fluidisation chamber. In addition, the indicators enable real-time monitoring of other 
pharmaceutical unit processes. The visual monitoring of colour is natural for humans and 
it can be very informative. In addition quantitative colour measurements are possible. 
 
The effect of particle size distribution on compression process was studied by collection 
of the samples during tabletting and analysing compression force data. The particle size 
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distribution changed during the tabletting, due to the segregation phenomenon. A granule 
batch with a broad particle size distribution causes more segregation problems during 
tabletting than a granule batch with smaller size distribution. Since the die is filled 
differently due to the segregation, it can induce variation of tablet weights and therefore 
quality problems of tablets. Different kind of particle size distributions can also induce 
undulation in the compression data and these changes can be divided into two different 
phenomenon: short-time scale variation and large-time scale undulation. Short-time scale 
variation was due to tablet-to-tablet changes in the force data during tabletting. Long-
time scale undulation described the changes during the whole tabletting process.  
The undulation phenomena can be analysed using mathematical methods. 
 
The studied methods were suitable for real-time monitoring of pharmaceutical unit 
operations. They can improve our process understanding and therefore, finally, enhance 
the quality of final products. 
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